PLoS ONE · 2015 · 52 citations · 19 references
Life SciencesCell BiologyPharmacologyApoptosisBiochemical PharmacologyPharmacodynamicsApoptotic SignalingMyocardial ProtectionOxidative Damage To BiomoleculesReactive Oxygen SpeciesMitogen-activated Protein Kinase CascadesMitogen-activated Protein Kinase PathwaysMyocardial Ischemia-reperfusion InjuryOxidative Stress InjuryReactive Oxygen Species GenerationReactive Oxygen Species InjuryReactive Oxygen Species-mediated Cell DeathStress-activated Protein Kinases
Myocardial ischemia/reperfusion (I/R) injury interferes with the restoration of blood flow to ischemic myocardium. Oxidative stress-elicited apoptosis has been reported to contribute to I/R injury. All-trans retinoic acid (ATRA) has anti-apoptotic activity as previously reported. Here, we investigated the effects and the mechanism of action of ATRA on myocardial I/R injury both in vivo and in vitro. In vivo, ATRA reduced the size of the infarcted area (17.81±1.05% vs. 24.41±1.03%, P<0.05) and rescued cardiac function loss (ejection fraction 46.42±6.76% vs. 37.18±4.63%, P<0.05) after I/R injury. Flow-cytometric analysis and TUNEL assay demonstrated that the protective role of ATRA on myocardial I/R injury was related to its anti-apoptotic effects. The anti-apoptotic effects of ATRA were associated with partial inhibition of reactive oxygen species (ROS) production and significantly less phosphorylation of mitogen-activated protein kinases (MAPKs) including p38, JNK, and ERK. Western blot analysis also revealed that ATRA pre-treatment increased a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) expression (0.65 ± 0.20 vs. 0.41±0.02 in vivo) and reduced the level of receptor for advanced glycation end-products (RAGE) (0.38 ± 0.17 vs. 0.52 ± 0.11 in vivo). Concomitantly, the protective role of ATRA on I/R injury was not observed in RAGE-KO mice. The current results indicated that ATRA could prevent myocardial injury and reduced cardiomyocyte apoptosis after I/R effectively. One possible mechanism underlying these effects is that ATRA could increase ADAM10 expression and thus cleave RAGE, which is the main receptor up-stream of MAPKs in myocardial I/R injury, resulting in the down-regulation of MAPK signaling and protective role on myocardial I/R injury.
19
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Patrick T. O’Gara, Frederick G. Kushner, Deborah D. Ascheim et al. · Circulation · 2012 · 4.7K citations
Angela Raucci, Simona Cugusi, Antonella Antonelli et al. · The FASEB Journal · 2008 · 542 citations
Receptor for Advanced-Glycation End Products
Loredana Bucciarelli, Michiyo Kaneko, Radha Ananthakrishnan et al. · Circulation · 2006 · 250 citations · Full text
Medicine, Cardiology, Pharmacology +15
Up‐regulation of the α‐secretase ADAM10 by retinoic acid receptors and acitretin
Frank Tippmann, Jana Hundt, Anja Schneider et al. · The FASEB Journal · 2009 · 216 citations